Surgical Science Sweden AB (publ) (SUS.ST)
Surgical Science Sweden AB (publ) operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Gothenburg, VG, SE. The stock last traded at $49.36, up 1.15% on the session, giving a market capitalisation of $2.52B. Its beta of 0.66 implies it has historically moved less than the broad market.
Surgical Science Sweden AB (publ) specializes in the creation and distribution of virtual reality (VR) simulation platforms designed for evidence-backed training in laparoscopic and endoscopic procedures. Among its key offerings is the LapSim training system, which includes LapSim ST, tailored for educating surgical technologists and assistants, as well as LapSim essence, a compact and readily deployable VR simulator. The company's product portfolio further extends to the EndoSim system, a dedicated endoscopy simulator for comprehensive medical training. It also features TeamSim, an innovative platform fostering inter-professional education by integrating surgical simulation with real-world team dynamics. Additionally, they provide the Simball Box, which delivers velocity feedback alongside instructional task videos demonstrating optimal techniques, alongside their well-known Simbionix and robotic surgery simulators. Established in 1999, Surgical Science AB maintains its headquarters in Gothenburg, Sweden.
Surgical Science Sweden AB (publ) is most often compared with the following Healthcare names: